Project: IWT SBO 130033: SAFE-PEDRUG: Integrating multidisciplinary translational bottom-up approaches towards a new paradigm for paedriatic investigations: the next step in ethical paediatric drug research
01/01/14 – 31/12/17
- Abstract
- IWT SBO 130033: SAFE-PEDRUG: Integrating multidisciplinary translational bottom-up approaches towards a new paradigm for paedriatic investigations: the next step in ethical paediatric drug research
Show
Sort by
-
"Onderzoeksstrategie binnen Pediatrie: ethische en strategische reflecties"
(2020) -
Chronotherapie en bioritmes
(2020) -
- Conference Paper
- open access
Enuresis: Evaluation and treatment
(2020) -
- Conference Paper
- open access
Etiologie and clinical features of enuresis
(2020) -
- Conference Paper
- open access
DRUG DEVELOPMENT FROM BENCH TO BEDSIDE @ UZGENT
(2020) -
- Conference Paper
- open access
SafePedrug / BPCRN + Belgium pediatric clinical research network
-
Het goed gebruik van 24 h ABPM / chronotherapie
-
An integrated paediatric population PK/PD analysis of dDAVP : how do PK differences translate to clinical outcomes?
-
The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model–based pediatric dose estimation
-
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies